Top 10 zifornd.com Wettbewerber

analytik-jena.us

This is a meta description. Please click!

lvl-technologies.com

Erfahren Sie, wie der Blutspendedienst West mit LVL SAFE® 2D Röhrchen die Archivierung von Blut- und Plasmaproben effizienter und sicherer gestaltet. Der neue Prozess spart Zeit, reduziert Fehler und unterstützt eine zuverlässige Langzeitlagerung gemäß nationalen Richtlinien.

slas.org

Connect with others in your area of interest and expertise through the SLAS Topical Interest Groups (TIGs). TIGs host a meeting during the SLAS International and SLAS Europe Conference and Exhibition. During the remainder of

lablynx.com

How small and mid-sized labs move from spreadsheets and Access databases to a first LIMS through a phased transition that keeps the lab running throughout.

msdclinicaltrials.com

Learn about MSD liver and bile duct cancer clinical trials and consider referring your patients with liver and bile duct cancer.

rxlogix.com

Webinar: From manual to AI-powered publishing with PV Publisher Most PV teams lose over half their publishing time on copy-pasting, annex stitching, and version chasing, Imagine eliminating this admin overhead, cutting timelines by more than 50%+ through true automation and AI. Join our RxLogix PV Publisher Agentic AI Webinar to see how leading safety operations teams

eclinicalsol.com

Join over 100 life sciences clients accelerating trials with elluminate® clinical data cloud and biometrics services. Power your digital data initiatives.

quantics.co.uk

FAQs About QuBAS What is QuBAS? QuBAS is a statistical analysis software package for bioassays. It is designed for relative potency and ELISA-type assays, and includes all standard models and suitability criteria. Who is QuBAS for? QuBAS is designed for anyone analysing bioassay data. Its Development mode gives you the flexibility to experiment with your...

veranahealth.com

Verana Health has introduced the largest curated real-world dataset for prostate cancer in the world. The dataset offers researchers comprehensive longitudinal insights into disease detection, treatment, and outcomes for patients affected with this malignancy.